FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT OTW CORONARY STENT SYSTEM

MDR report key: 2080533 · Received April 22, 2011

Report

Report Number
9612164-2011-00288
Event Type
Injury
Date Received
April 22, 2011
Date of Event
December 21, 2010
Report Date
March 25, 2011
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL RESULTS: NO CONCLUSION CAN BE DRAWN. REACTION.

Description of Event or Problem · 1

FOLLOWING A MYOCARDIAL INFARCTION APPROXIMATELY 5 MONTHS AGO, A 2.50 MM DIAMETER X 12MM LENGTH ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENT WAS IMPLANTED IN A PT. LATER THE SAME MONTH, THE PT EXPERIENCED SYMPTOMS OF HYPOTENSION, TINGLING AND NUMBNESS IN THE FEET AND LEG, ARRHYTHMIA (TACHYCARDIA) AND CHEST PAIN. THE FOLLOWING MONTH, THE PT WAS RE-ADMITTED TO THE CARDIAC UNIT AND THE STRESS TEST CARRIED OUT WAS NORMAL. TWO MONTHS LATER, THE PT EXPERIENCED INCREASING CHEST PAIN, WITH FREQUENT "STABBING" PAIN IN THE HEART. THE FOLLOWING MONTH, THE PT WENT TO THE ER WITH INCREASING CHEST PAIN AND A PULSE RATE OF 150. CARDIAC ENZYMES WERE NORMAL AT THIS TIME. SEVERAL DAYS LATER, THE PT WAS RE-ADMITTED TO THE CARDIAC UNIT AGAIN WITH INCREASING CHEST PAIN AND AGAIN THE STRESS TEST CARRIED OUT WAS NORMAL AND ALSO THE NUCLEAR SCAN. THE PT IS CURRENTLY UNDER THE CARE OF AN ALLERGIST. THE STENT DELIVERY SYSTEM WAS NOT RETURNED FOR EVAL. NO ADD'L CLINICAL SEQUELAE WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT OTW CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA 002833271

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization| O PLAVIX| METANX| PHENERGAN| ALTACE| METOPROLOL| TRAMADOL| LOVAZA| NITROSTAT| ASPIRIN